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BACKGROUND: Tuberculosis (TB) is a cause of 1.2-1.5 million deaths worldwide, including deaths 
from TB among HIV positive people. Determining the extent of immune cells belonging to cell mediated 
immunity and haematological parameters is critical to maximize the potential benefit of anti-tubercular 
treatment and case management. 
MATERIALS AND METHODS: Comparative cross sectional study was conducted to determine the 
white blood cell (WBC) count, CD4, CD8, haemoglobin (Hgb), red blood cell (RBC) count, mean 
corpuscular haemoglobin (MCHC), mean corpuscular volume (MCV) between newly diagnosed TB 
patients and apparently healthy controls (HCs).  
RESULTS: From consecutively enrolled 108 TB patients, pulmonary TB (PTB) accounted for 
48(44.4%), TB lymphadenitis accounted for 48(44.4%), and disseminated/miliary TB accounted for 
12(11.1%). Analysis of variance revealed that mean + SD of CD4 count of male TB patients (650 + 
224cells/µl) was significantly lower than male control group (883 + 256 cells/µl) (p= 0.001). In a similar 
manner, the mean CD4 count of female TB patients (793 + 332cells/µl) was lower than female control 
group (975 + 300 cells/µl) (p=0.001). There was no statistically significant difference in CD8 counts 
between cases and controls for both genders. Forty (37.0%) TB patients had developed anaemia of whom 
22(55%) were among PTB, 13(32.5%) from tuberculous lymphadenitis and 5(20%) from disseminated 
TB. Morphologically, from all anaemia among TB patients, normocytic normochromic anaemia 
accounted for 15(37.5%) followed by normocytic hypochromic anaemia 13(30.4%). 
CONCLUSION: CD4 lymphopenia was significant among TB patients. Granulocyte count was increased. 
Mild anaemia was found major haematological abnormality among newly diagnosed TB patients. 
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TB was declared a global emergency in 1993. In 
that  year an estimated 7–8 million cases and 1.3–
1.6 million deaths occurred (1). Despite the 
availability of effective treatment, TB remains a 
major global health problem. After about a decade 
in 2010, there were an estimated 8.5–9.2 million 
cases and 1.22–1.59 million deaths including 
deaths from Human Immunodeficiency Virus 
(HIV)-associated TB (2). Hospital data of the 
Ministry of health in Ethiopia show that TB is the 
leading cause of morbidity, the third cause of 
hospital admission, and the first cause of hospital 
death in Ethiopia (3). According to WHO Global 
Report of 2011, Ethiopia ranked 7th among the 
high TB burden countries in the world, with an 
estimated incidence of all forms of TB of 
261/100,000 population/year. The estimated 
prevalence of all forms of TB reported was 
394/100,000 population (2).  
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M. tuberculosis targets macrophages which are 
important effector cells in the immune system, as 
its preferred habitat. Whereas resting macrophages 
fail to harm M. tuberculosis, activated 
macrophages can control the growth of the 
microbe, although sterile eradication is seldom 
achieved. Several different T-cell populations are 
required for the successful control of the pathogen. 
This dynamic interplay underlying protection is 
the reason for the long-term persistence of M. 
tuberculosis (4). CD4 lymphocytopenia is a well-
defined risk factor for the development of active 
TB in patients infected with HIV.  TB may be also 
associated with CD4 and CD8 lymphopenia even in 
patients without HIV virus infection (5). 
CD4 T cells play central roles in the function 
of the immune system: They help B cells make 
antibody, enhance and maintain responses of CD8 
T cells, regulate macrophage function, orchestrate 
immune responses against a wide variety of 
pathogenic microorganisms, and regulate/suppress 
immune responses both to control autoimmunity 
and to adjust the magnitude and persistence of 
responses. CD4 T cells are important mediators of 
immunologic memory, and when their numbers 
are diminished or their functions are lost, the 
individual becomes susceptible to a wide range of 
infectious disorders including TB (6).  
The protective and pathologic response to M. 
tuberculosis is complex and multifaceted, 
involving many components of the immune 
system. A clear picture of the network of immune 
responses to this pathogen, as well as an 
understanding of the effector functions of these 
components is essential to the design and 
implementation of effective treatments for TB (7).  
It is essential to determine immunological and 
haematological parameters at the baseline of anti-
TB treatment for further consideration of 
supportive care and other treatment options that 
might be required for some patients to enhance the 
anti-TB treatment outcome. 
 
MATERIALS AND METHODS 
 
A Comparative cross-sectional study was 
conducted between TB patients and apparently 
healthy controls at Jimma University Specialized 
Hospital TB clinic from January- 2012 to May-
2012. One hundred eight newly diagnosed TB 
patients and 116 HIV negative apparently healthy 
controls in the age group of 15-55 years were 
included in the study consecutively. The diagnosis 
of TB was made according to the national 
guideline. The cases were reportedly naive to anti-
TB treatment.  Newly diagnosed TB patients who 
have already started anti-TB treatment, receiving 
any kind of immunosuppressive drugs, known or 
suspected history of other chronic disease, 
pregnant women and HIV positive individuals 
were excluded. Apparently healthy controls were 
recruited from blood donors   15-55 years of age.  
Data was collected during enrolment using 
pre-structured questionnaire. Four milliliters of 
blood specimen was collected in pre-labelled 
evacuated tubes (BD vacutainer, Oxford, UK) 
from each study participant. CD4, CD8 and CD4/ 
CD8 ratio counts were performed on BD- FACS 
Count System (Becton Dickinson Biosciences, 
San Jose California, USA) and CBC was done on 
Cell-Dyn 1800 system (Abbott Diagnostic, 
Illinois, USA). Data from the laboratory 
investigation and questionnaire were compiled and 
analyzed using SPSS 16.0. Mean values were 
calculated and compared using one way ANOVA 
test for TB patients and apparently healthy 
controls. Significant differences were evaluated 
between groups by Post Hoc Tukey test. P value < 
0.05 was considered statistically significant. The 
study was approved by the Ethical Review Board 
of Jimma University, College of Public Health and 
Medical sciences, Department of Medical 
Laboratory Science and Pathology. The objective 
of the study was explained to the patients and all 
the study subjects (cases and controls) were 




A total of 108 newly diagnosed TB patients and 
116 healthy controls were enrolled in this study. 
Cases accounted for 45(41.7%) males and 
63(58.3%) females, and healthy controls account 
for 54(46.6%) males and 62(53.4%) females. 
There was no statistically significant difference 
between the mean age (p=0.094) and sex 
distribution (p=0.599) of the TB patients and 
healthy controls. Distribution of age, sex, 
educational status and body mass index (BMI) 
among newly diagnosed TB patients is shown in 
(Table 1).  









Type of TB  
Total TBL DTB P TB 
Age category     
16-20 9(8.3%) 2(1.9%) 13(12%) 24(22.2%) 
21-25 8(7.4%) 3(2.8%) 13(12%) 24(22.2%) 
26-30 11(10.2%) 0 11(10.2%) 22(20.4%) 
31-35 7(6.4%) 1(0.9%) 2(1.9%) 10(9.2%) 
36-40 6(5.6%) 1(0.9%) 1(0.9%) 8(7.4%) 
41-45 2(1.9%) 0 4(3.7%) 6(5.6%) 
46-50 4(3.7%) 4(3.7%) 0 8(7.4%) 
51-55 1(0.9%) 1(0.9%) 4(3.7%) 6(5.6%) 
Total  48(44.4%) 12(11.1%) 48(44.4%) 108(100%) 
Gender (sex)     
Male 18(16.7%) 4(3.7%) 23(21.3%) 45(41.7%) 
Female 30(27.8%) 8(7.4%) 25(23.1%) 63(58.3%) 
Total 48(44.4%) 12(11.1%) 48(44.4%) 108(100%) 
Educational Status     
Illiterate 27(25.0%) 7(6.5%) 13(12%) 47(43.5%) 
Only read and Write  1(0.9%) 0 1(0.9%) 2(1.9%) 
1-4
th
 3(2.8%) 1(0.9%) 6(5.6%) 10(9.3%) 
5-8
th





 9(8.3%) 2(1.9%) 19(17.6%) 30(27.8%) 
Total 48(44.4%) 12(11.1%) 48(44.4%) 108(100%) 
BMI      
<18.5 kg/m
2
 20(18.5%) 7(6.5%) 33(30.6%) 60(55.6%) 
18.5-255 kg/m
2
 28(25.9%) 5(3.6%) 15(13.9%) 48(44.4%) 
Total 48(44.4%) 12(11.1%) 48(44.4%) 108(100%) 
TBL= tuberculous lymphadenitis, DTB= disseminated TB, PTB=pulmonary TB 
 
From the total of 108 cases, PTB accounts 
48(44.4%), TB lymphadenitis (TBL) 48(44.4%) 
and disseminated/miliary TB (DTB) accounts 
12(11.1%) (Table 1). Compared with male healthy 
controls (6.83 ± 2.17 x10
3
cells/µl) male TB 
patients had significantly high mean absolute 
WBC count (8.35±3.3 x10
3
cells/µl) (p=007). 
Female TB patients also had significantly high 
mean absolute WBC count (8.62±2.89 
x10
3
cells/µl) than female healthy controls 
(6.67±1.5x10
3
cells/µl) (p=0.001). The mean 
absolute granulocytes count (AGC) of both male 
and female TB patients were significantly higher 
than healthy controls (p=0.001). Absolute 
lymphocytes counts of male TB patients were 
significantly lower compared with male healthy 
controls (p=0.008). But, there was no statistically 
significant difference between female TB patients 





and female healthy controls (p=0.101) (Table 2). 
Mean CD4 count of male TB patients (650 ± 
224cells/µl) were significantly lower than male 
healthy controls (883 + 256 cells/µl) (p=001). 
Similarly, the mean CD4 count of female TB 
patients (793±332 cells/µl) is lower than the mean 
CD4 count of female healthy controls (975 + 300 
cells/µl) (p=0.002). But, in case of CD8 count, 
there was no statistically significant difference 
between cases and controls in both genders (Table 
2). 
 
Table 2: Comparison of mean values of immunological and hematological parameters in the newly 
diagnosed TB patients versus healthy control 
 
               Male             Female 
TB patient 
mean + SD 
HC mean 
+ SD 
P-value TB patient 






cells/µl 8.35+ 3.3 6.83 + 2.17 0.007 8.62 ±  2.89 6.67 ± 1.5 0.001 
AGC x10
3
cells/µl 5.62 + 2.97 3.9 + 1.85 0.001 5.65 ±2.67 3.66 ± 1.22 0.001 
ALC  x 10
3
cells /µl 1.90 ± 0.52 2.2 ± 0.58 0.008 2.07 ±0.81 2.28 ± 0.55 0.101 
CD4cells /µl
 
650 ± 224 883 ±256 0.001 793±332 975±300 0.002 
CD8 cells/µl 612± 266 675 ±277 0.256 640±290 712±260 0.217 
CD4/CD8 ratio 1.17 ± 0.44  1.41 ± 0.46 0.009 1.59 ± 0.95 1.44 ±0.43 0.268 
RBC x 10
6
cells /µl 4.95 ±1.58 5.81 ± 0.74 0.001 4.74 ±0.99 5.24±0.74 0.001 
Hgb g/dl  13.3 ± 4.6 17.1 ± 2.2 0.001 12.5±3.6 14.9 ± 2.2 0.001 
MCV fl 88.0 ± 14 94 ±5.8 0.001 87 ±14.7 93.2±7.2 0.001 
MCHC g/dl 32.09 ± 2.18 33.34±0.82 0.001 32 ± 2.6 33 ± 0.8 0.001 
PLT x 10
3
cells /µl 455.9 ± 329 315 ±124 0.001 442± 317 340±144 0.001 
HC= healthy controls 
  
Further analysis using Post Hoc Tukey test 
showed that mean CD4 cells count of DTB group 
was significantly lower than TBL (p=0.034) and 
healthy control group (p<0.001) but showed no 
statistically significant  difference with PTB 
(0.884). Mean CD4 cells count of PTB also lower 
than TBL (p=0.009) and healthy control group 
(p=0.001) (Fig. 1). Of the total 108 TB patients 
24(22.2%) had low CD4 count (<500cells/µl), of 




Figure 1: Comparson of mean CD4 count between different tuberculosis group; TBL (Tuberculoous 
lymphadnitis), DTB (Dissiminated TB), PTB (Pulmonary TB) and healthy control (HC)  




Mean + SD of RBC counts, haemoglobin (Hgb), 
MCV, MCH and MCHC values of TB patients 
were significantly lower than those  male and 
female healthy controls (p=0.001). Platelet counts 
and red cell distribution width (RDW) were 
significantly higher in both sexes among cases 
than controls (p=0.001) (Table 2). Further analysis 
by Post Hoc Tukey test showed mean Hgb values 
of all groups of TB patients were lower than those 
of control group (p=0.001). Mean Hgb values of 
PTB group were also lower than TBL (p=0.028) 
and no statistical significant difference between 
PTB and DTB cases were observed (p=0.941) 
(Fig. 2). From cases, 40(37.0%) were found 
anaemic of whom 38(95.0%) had moderate 
anaemia and 2(5.0%) severe anaemia. From these 
40 anaemic cases, 13(32.5%) were among TBL, 
5(12.5%) among DTB and 22(55.0%) among 
PTB. The RBC morphology and RBC indices in 
our study showed that 15(37.5%) of cases 
developed normocytic normochromic anaemia 
followed by normocytic hypochromic anaemia, 
13(32.6%), (Table 3). From a total of 53(49.1%) 
thrombocytosis, PTB accounted for 26(49.1%), 
TBL for 21(39.6%) and DTB for 6(11.3%). 
 
 
Figure. 2: Comparson of mean Hemoglobine (Hgb) value between diffirent tuberculosis group; TBL 
(Tuberculous lymphadnitis), DTB (Dissiminated TB) PTB (Pulmonary TB) and healthy control (HC) 
 
Table 3: Classification of anemia, red cell morphology and indices among newly diagnosed TB patients  
                                                  MCHC(pg) Total 
 Hypochromic Normochromic  
MCV (fl) Microcytic 8(20%) 2(5%) 10(25%) 
Normocytic 13(32.5 %) 15(37.5%) 28(70%) 
Macrocytic 2(5%) 0 2(5%) 
Total  23(57.5%) 17(42.5%) 40(100%) 




M. tuberculosis has a variety of surface molecules 
that interact with the innate host response. The 
interaction of the bacterial surface molecules 
along with the auto-regulation of the immune 
response by several mechanisms results in less 
optimal conditions for control of bacterial growth 





(4). M. tuberculosis is a classic example of a 
pathogen for which the protective response relies 
on cell mediated immunity. . Both CD4 and CD8 
T-cells are important for successful immunity to 
TB (8).  
In our finding, the mean CD4 count of both 
male and female TB patients was significantly 
lower than that of the respective healthy control. 
Absolute CD8 count has no significant difference 
between TB patients and healthy controls in both 
sexes. CD4/CD8 ratio in male TB patients was 
decreased relative to male healthy controls but in 
female TB patients, there is no significant 
difference in CD4/CD8 ratio with female healthy 
controls. The finding of our study is comparable to 
a study conducted in Pune, India, among 39 male 
patients who were HIV negative but PTB positive. 
The study showed that CD4 counts were 
significantly lower, CD8 values were normal in 
patients with PTB when compared with values 
obtained in normal blood donors. The CD4/CD8 
ratio was significantly lower in patients with TB 
(9).  
Another similar study conducted in Tan Tock 
Seng Hospital in Singapore on 60 patients showed 
that patients with TB had a lower median absolute 
lymphocyte count, lower CD8 count and a trend 
towards a lower CD4 count when compared to 
controls (10).  A study done in Turkey on 75 
active PTB patients has shown reduced percentage 
of circulating CD4 T cells and CD8 T cells 
compared with healthy individuals (11). A study 
from United States conducted on 85 HIV negative 
patients also reported comparable findings (12). 
The low mean CD4 count among TB patient than 
healthy controls in this study is also comparable 
with the finding of other studies (5, 10, 12-16).  
In our study, the CD4 count of TB patients is 
compared against the type of TB. Lower CD4 
count was recorded among cases of disseminated 
TB than tuberculous lymphadenitis but no 
significant difference was observed with PTB. 
Similar to study from Guangzhou Chest Hospital, 
China, our study revealed that CD4 count from 
patients of disseminated TB was lower than 
patients with PTB (16). But, a study done in 
Tehran showed that mean CD4 count of 
disseminated TB was lower than all other types of 
TB (15).  In another study done on PTB in Turkey 
and in E. Tornu Hospital, Argentina, introduced 
that mean CD4 count significantly decreased in 
patients than control groups (11, 17).  Similar with 
other previous studies (9, 17), the difference in 
mean CD8 count between the cases and control 
was not statistically significant in our finding.  
Mean RBC counts, Hgb, MCV, MCH and 
MCHC values were significantly lower than the 
corresponding control group for both males and 
females. From 40(37%) study subjects who 
developed anaemia, 15(32.6%) had normocytic 
normochromic anaemia followed by 13(32.5%) 
those who normocytic hypochromic anaemia. 
Other similar studies have reported lower 
haemoglobin levels among TB patients (13, 18-
21). However, study conducted on adult patients 
diagnosed with TB at Seoul National University 
Hospital, Korea among 880 patients, anaemia was 
identified in 281 patients (31.9%) at the time of 
diagnosis [19] which was lower than the present 
study. It also showed that Normocytic 
normochromic anaemia was most common and 
identified in 202 (71.9%) patients and followed by 
microcytic hypochromic anaemia 26(9.1%) (19).  
On the other hand,  a study conducted in India 
reported  normocytic normochromic anaemia as 
the most common abnormality observed in all 
cases, groups and subgroups (DTB/MTB 84%, 
PTB 86%) (18). The variation might be due to the 
difference in the stage of the disease during 
diagnosis, geographic, nutrition and other cultural 
differences that may directly or indirectly be 
related to anaemia. 
The platelet counts of newly diagnosed TB 
patients among PTB patients were higher as 
compared to healthy controls. A study conducted 
at India Institute of Medical Sciences, New Delhi, 
on 32 DTB and 23 PTB indicated that 
thrombocytopenia was more common in patients 
with disseminated/miliary TB, whereas 
thrombocytosis was more common in patients 
with PTB (18). A study in Sao Paulo State 
University, Brazil, on 80 PTB patients revealed 
that platelet count values were higher in those with 
less clinical disease duration (22). This was, 
because of the fact that, at the beginning of the TB 
process, there was strong pro-inflammatory 
cytokine activity (IFN-γ & TNF-α) which 
stimulates expression of acute-phase proteins and 
thrombocytosis. 
This study demonstrated that the mean CD4 
count is significantly lower in newly diagnosed 
TB patients when compared with apparently 




healthy control for both male and female. The 
mean CD8 count is comparable among cases and 
control groups. Haematological parameters like 
RBC count, Hgb, MCV and MCHC were 
significantly lower when compared with healthy 
controls. Morphologically normocytic 
normochromic anaemia is a common 
haematological abnormality among TB patients. 
Increased thrombocytosis was observed among 
newly diagnosed treatment naive TB patients. 
Our study was not without pitfalls. First, 
apparently healthy controls were recruited 
depending only from the blood bank information. 
Second, due to logistic reasons, in-depth 
characterization of immune cells to appreciate 
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